These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38124143)

  • 1. Clinicopathologic features of two unrelated autopsied patients with Charcot-Marie-Tooth disease carrying MFN2 gene mutation.
    Hayashi H; Saito R; Tanaka H; Hara N; Koide S; Yonemochi Y; Ozawa T; Hokari M; Toyoshima Y; Miyashita A; Onodera O; Okamoto K; Ikeuchi T; Nakajima T; Kakita A
    Acta Neuropathol Commun; 2023 Dec; 11(1):207. PubMed ID: 38124143
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study.
    Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H
    J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
    Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
    J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MFN2 transcripts escaping from nonsense-mediated mRNA decay pathway cause Charcot-Marie-Tooth disease type 2A2.
    Kawarai T; Yamasaki K; Mori A; Takamatsu N; Osaki Y; Banzrai C; Miyamoto R; Oki R; Pedace L; Orlacchio A; Nodera H; Hashiguchi A; Higuchi Y; Takashima H; Nishida Y; Izumi Y; Kaji R
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1263-1265. PubMed ID: 27154191
    [No Abstract]   [Full Text] [Related]  

  • 5. Cavitating leukodystrophy as a manifestation of cerebral involvement in MFN2 neuropathy.
    Manokaran RK; Mahalingam HV; Kewalramani D
    Neurology; 2020 Jul; 95(1):42-43. PubMed ID: 32522799
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitochondrial GTPase mitofusin 2 mutations in Korean patients with Charcot-Marie-Tooth neuropathy type 2.
    Cho HJ; Sung DH; Kim BJ; Ki CS
    Clin Genet; 2007 Mar; 71(3):267-72. PubMed ID: 17309650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MFN2 mutations in Charcot-Marie-Tooth disease alter mitochondria-associated ER membrane function but do not impair bioenergetics.
    Larrea D; Pera M; Gonnelli A; Quintana-Cabrera R; Akman HO; Guardia-Laguarta C; Velasco KR; Area-Gomez E; Dal Bello F; De Stefani D; Horvath R; Shy ME; Schon EA; Giacomello M
    Hum Mol Genet; 2019 Jun; 28(11):1782-1800. PubMed ID: 30649465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
    Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
    Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A late-onset and mild form of Charcot-Marie-Tooth disease type 2 caused by a novel splice-site mutation within the Mitofusin-2 gene.
    Kotruchow K; Kabzińska D; Hausmanowa-Petrusewicz I; Kochański A
    Acta Myol; 2013 Dec; 32(3):166-9. PubMed ID: 24803844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcot-Marie-Tooth disease type 2A with an autosomal-recessive inheritance: the first report of an adult-onset disease.
    Hikiami R; Yamashita H; Koita N; Jingami N; Sawamoto N; Furukawa K; Kawai H; Terashima T; Oka N; Hashiguchi A; Takashima H; Urushitani M; Takahashi R
    J Hum Genet; 2018 Jan; 63(1):89-92. PubMed ID: 29215088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Marie-Tooth Disease Associated With a Novel Mutation in MFN2 Presenting With Subacute Vision Loss.
    Li Y; Aleman TS; Quinn CC; Xia T; Miller CG; Kim BJ; Tamhankar MA
    J Neuroophthalmol; 2022 Mar; 42(1):e381-e384. PubMed ID: 34924536
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations.
    Amiott EA; Lott P; Soto J; Kang PB; McCaffery JM; DiMauro S; Abel ED; Flanigan KM; Lawson VH; Shaw JM
    Exp Neurol; 2008 May; 211(1):115-27. PubMed ID: 18316077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
    Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
    Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: Case report and literature review.
    Tan CA; Rabideau M; Blevins A; Westbrook MJ; Ekstein T; Nykamp K; Deucher A; Harper A; Demmer L
    Am J Med Genet A; 2016 Jun; 170(6):1580-4. PubMed ID: 26955893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fifteen-year longitudinal follow-up of a patient with severe early-onset Charcot-Marie-Tooth disease type 2A.
    McCray BA; Hurst W; Crawford TO; Lloyd TE
    Muscle Nerve; 2018 May; 57(5):E126-E128. PubMed ID: 29266326
    [No Abstract]   [Full Text] [Related]  

  • 16. MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives.
    Stuppia G; Rizzo F; Riboldi G; Del Bo R; Nizzardo M; Simone C; Comi GP; Bresolin N; Corti S
    J Neurol Sci; 2015 Sep; 356(1-2):7-18. PubMed ID: 26143526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MFN2-related Charcot-Marie-Tooth Disease with Atypical Ocular Manifestations.
    Nan H; Hata T; Fukao T; Fukao T; Chen W; Kurita T; Natori T; Takiyama Y
    Intern Med; 2021 Dec; 60(24):3969-3974. PubMed ID: 34121014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation of the MFN2 gene in a Chinese family with Charcot-Marie-Tooth disease.
    Wang YW; Han WT; Jiang M; Lu CX; Li XF; Zhang X; Li JX
    Genet Mol Res; 2012 May; 11(2):1454-9. PubMed ID: 22653593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A.
    Kijima K; Numakura C; Izumino H; Umetsu K; Nezu A; Shiiki T; Ogawa M; Ishizaki Y; Kitamura T; Shozawa Y; Hayasaka K
    Hum Genet; 2005 Jan; 116(1-2):23-7. PubMed ID: 15549395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-dominant mutations in MFN2-related neuropathy and implications for genetic counselling.
    Tomaselli PJ; Rossor AM; Polke JM; Poh R; Blake J; Reilly MM
    J Peripher Nerv Syst; 2016 Mar; 21(1):52-4. PubMed ID: 26930221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.